{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:53:18Z","timestamp":1774327998705,"version":"3.50.1"},"reference-count":25,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/ol.2015.3134","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T11:49:13Z","timestamp":1429616953000},"page":"2694-2700","source":"Crossref","is-referenced-by-count":11,"title":["Endostar inhibits ascites formation and prolongs survival in mouse models of malignant ascites"],"prefix":"10.3892","volume":"9","author":[{"given":"HONGMEI","family":"WEI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUKUI","family":"QIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOJIN","family":"YIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YALI","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAIQING","family":"HUA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NINGRONG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YINGXIA","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIUFENG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"key20180108103622_b1-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1684\/bdc.2011.1373","article-title":"Pathogenesis and management of refractory malignant ascites","volume":"98","author":"Sa\u00e2da","year":"2011","journal-title":"Bull Cancer"},{"key":"key20180108103622_b2-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/clon.2002.0135","article-title":"The current and future management of malignant ascites","volume":"15","author":"Smith","year":"2003","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20180108103622_b3-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11864-008-0068-y","article-title":"Treatment of malignant ascites","volume":"9","author":"Chung","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"key20180108103622_b4-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejca.2005.11.018","article-title":"Malignant ascites: systematic review and guideline for treatment","volume":"42","author":"Becker","year":"2006","journal-title":"Eur J Cancer"},{"key":"key20180108103622_b5-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-05-1181","article-title":"Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice","volume":"12","author":"Pourgholami","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180108103622_b6-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-08-0177","article-title":"Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites and progression of ovarian cancer","volume":"7","author":"Agarwal","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180108103622_b7-ol-0-0-3134","first-page":"1899","article-title":"Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites","volume":"4","author":"Beattie","year":"1998","journal-title":"Clin Cancer Res"},{"key":"key20180108103622_b8-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1634\/theoncologist.2009-0109","article-title":"Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?","volume":"14","author":"Kobold","year":"2009","journal-title":"Oncologist"},{"key":"key20180108103622_b9-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"key20180108103622_b10-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.yexcr.2005.11.015","article-title":"Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action","volume":"312","author":"Folkman","year":"2006","journal-title":"Exp Cell Res"},{"key":"key20180108103622_b11-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/JCO.2003.12.120","article-title":"Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors","volume":"21","author":"Thomas","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180108103622_b12-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2002.11.061","article-title":"Phase I study of recombinant human endostatin in patients with advanced solid tumors","volume":"20","author":"Herbst","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180108103622_b13-ol-0-0-3134","first-page":"478","article-title":"Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect","volume":"61","author":"Huang","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108103622_b14-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/JTO.0b013e3182166b6b","article-title":"A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with Endostar for advanced non-small cell lung cancer","volume":"6","author":"Han","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key20180108103622_b15-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3748\/wjg.v13.45.6115","article-title":"Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection","volume":"13","author":"Sun","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20180108103622_b16-ol-0-0-3134","first-page":"1","article-title":"Spreading depression - cortical reactions: disorders of the extracellular microenvironment","volume":"21","author":"Lehmenk\u00fchler","year":"1990","journal-title":"EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb"},{"key":"key20180108103622_b17-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1525-1438.2006.00777.x","article-title":"Ascites and epithelial ovarian cancers: a reappraisal with respect to different aspects","volume":"17","author":"Ayhan","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"key20180108103622_b18-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.93.25.14765","article-title":"Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor\/vascular permeability factor antibody","volume":"93","author":"Yuan","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108103622_b19-ol-0-0-3134","first-page":"647","article-title":"Avastin combined with cisplan inhibits malignant ascites production in nude mice bearing transplanted ovary carcinoma with high VEGF expression","volume":"27","author":"Cai","year":"2007","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180108103622_b20-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.rmed.2010.10.010","article-title":"Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma","volume":"105","author":"Hirayama","year":"2011","journal-title":"Respir Med"},{"key":"key20180108103622_b21-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000065723","article-title":"High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer","volume":"63","author":"Ishimoto","year":"2002","journal-title":"Oncology"},{"key":"key20180108103622_b22-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.5-suppl_1-45","article-title":"Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation","volume":"5","author":"Verheul","year":"2000","journal-title":"Oncologist"},{"key":"key20180108103622_b23-ol-0-0-3134","first-page":"168","article-title":"Frontiers in congestive heart failure: consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem","volume":"6","author":"Tepper","year":"2000","journal-title":"Congest Heart Fail"},{"key":"key20180108103622_b24-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.06.155","article-title":"Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR\/Flk-1 of endothelial cells","volume":"361","author":"Ling","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108103622_b25-ol-0-0-3134","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.febslet.2007.05.058","article-title":"Contributions of Zn(II)-binding to the structural stability of endostatin","volume":"581","author":"Han","year":"2007","journal-title":"FEBS Lett"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2015.3134\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T21:43:24Z","timestamp":1566596604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2015.3134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,4,21]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/ol.2015.3134"],"URL":"https:\/\/doi.org\/10.3892\/ol.2015.3134","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}